HK1014440A1 - Trisubstituted phenyl derivatives - Google Patents

Trisubstituted phenyl derivatives

Info

Publication number
HK1014440A1
HK1014440A1 HK98112775A HK98112775A HK1014440A1 HK 1014440 A1 HK1014440 A1 HK 1014440A1 HK 98112775 A HK98112775 A HK 98112775A HK 98112775 A HK98112775 A HK 98112775A HK 1014440 A1 HK1014440 A1 HK 1014440A1
Authority
HK
Hong Kong
Prior art keywords
pct
phenyl derivatives
trisubstituted phenyl
date sep
sec
Prior art date
Application number
HK98112775A
Other languages
English (en)
Inventor
Peter Nussbaumer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9505080.3A external-priority patent/GB9505080D0/en
Priority claimed from GBGB9505858.2A external-priority patent/GB9505858D0/en
Priority claimed from GBGB9526593.0A external-priority patent/GB9526593D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1014440A1 publication Critical patent/HK1014440A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
HK98112775A 1995-03-14 1998-12-03 Trisubstituted phenyl derivatives HK1014440A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9505080.3A GB9505080D0 (en) 1995-03-14 1995-03-14 Organic compounds
GBGB9505858.2A GB9505858D0 (en) 1995-03-23 1995-03-23 Organic Compounds
GBGB9526593.0A GB9526593D0 (en) 1995-12-28 1995-12-28 Organic compounds
PCT/EP1996/001116 WO1996028430A1 (en) 1995-03-14 1996-03-14 Trisubstituted phenyl derivatives

Publications (1)

Publication Number Publication Date
HK1014440A1 true HK1014440A1 (en) 1999-09-30

Family

ID=27267624

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98112775A HK1014440A1 (en) 1995-03-14 1998-12-03 Trisubstituted phenyl derivatives

Country Status (24)

Country Link
US (1) US5990116A (sk)
EP (1) EP0815087B1 (sk)
JP (1) JP3194963B2 (sk)
KR (1) KR100437580B1 (sk)
CN (1) CN1101386C (sk)
AT (1) ATE208763T1 (sk)
AU (1) AU704544B2 (sk)
BR (1) BR9607240A (sk)
CA (1) CA2214131C (sk)
CZ (1) CZ289944B6 (sk)
DE (1) DE69616993T2 (sk)
DK (1) DK0815087T3 (sk)
ES (1) ES2168463T3 (sk)
FI (1) FI120537B (sk)
HK (1) HK1014440A1 (sk)
HU (1) HUP9801828A3 (sk)
MX (1) MX9707022A (sk)
NO (1) NO310356B1 (sk)
NZ (1) NZ304291A (sk)
PL (1) PL185875B1 (sk)
PT (1) PT815087E (sk)
RU (1) RU2164224C2 (sk)
SK (1) SK282155B6 (sk)
WO (1) WO1996028430A1 (sk)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747498A (en) 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
US6706721B1 (en) 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
UA71945C2 (en) 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
JP3270834B2 (ja) 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク 抗がん剤として有用なヘテロ芳香族二環式誘導体
UA74803C2 (uk) 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
US7087613B2 (en) 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
JP4665331B2 (ja) * 2000-04-07 2011-04-06 チッソ株式会社 新規なジアミノ化合物、該ジアミノ化合物を用いて合成された重合体、並びに該重合体を用いたワニス、配向膜及び液晶表示素子
BR0213233A (pt) * 2001-10-12 2005-01-04 Warner Lambert Co Alcinos inibidores de metaloproteinase de matriz
US7053216B2 (en) 2001-11-19 2006-05-30 Iconix Pharmaceuticals, Inc. Modulators of Rho C activity
MXPA05000638A (es) * 2002-07-17 2005-03-31 Warner Lambert Co Combinacion de un inhibidor alquino alosterico de metaloproteinasa-13 de matriz con un inhibidor selectivo de ciclooxigenasa-2 que no es celecoxib o valdecoxib.
WO2004006914A1 (en) * 2002-07-17 2004-01-22 Warner-Lambert Company Llc Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib
WO2004014384A2 (en) * 2002-08-13 2004-02-19 Warner-Lambert Company Llc Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
GB0319497D0 (en) * 2003-08-19 2003-09-17 Novartis Ag Organic compounds
SE0400234D0 (sv) * 2004-02-06 2004-02-06 Active Biotech Ab New compounds, methods for their preparation and use thereof
US20080044439A1 (en) * 2004-03-11 2008-02-21 David Nathaniel E Compositions and Methods for Preventing and Treating Skin and Hair Conditions
US20080031898A1 (en) * 2004-03-26 2008-02-07 David Nathaniel E Compositions and methods to increase the effect of a neurotoxin treatment
GB0412769D0 (en) * 2004-06-08 2004-07-07 Novartis Ag Organic compounds
RU2424232C2 (ru) * 2004-08-04 2011-07-20 Мейдзи Сейка Кайся, Лтд. Производные хинолина и инсектициды, включающие их в качестве активного ингредиента
WO2008044688A1 (fr) * 2006-10-11 2008-04-17 Daiichi Sankyo Company, Limited Dérivé de l'urée
AU2008213147A1 (en) * 2007-02-06 2008-08-14 Chelsea Therapeutics, Inc. New compounds, methods for their preparation and use thereof
AU2019232437A1 (en) 2018-03-07 2020-10-08 Bayer Aktiengesellschaft Identification and use of ERK5 inhibitors
WO2021026672A1 (en) * 2019-08-09 2021-02-18 Novartis Ag Heterocyclic wdr5 inhibitors as anti-cancer compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3066406D1 (en) * 1979-09-13 1984-03-08 Wellcome Found Diaryl compounds and pharmaceutical formulations containing them
CA1219587A (en) * 1981-12-14 1987-03-24 Norman P. Jensen Hydroxybenzylaminobenzenes as anti-inflammatory agents
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
WO1988003800A1 (en) * 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Lipoxygenase inhibitors
WO1988003806A1 (en) * 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Pharmacologically active compositions of catecholic butanes with zinc
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US5272167A (en) * 1986-12-10 1993-12-21 Schering Corporation Pharmaceutically active compounds
EP0407217A1 (en) * 1989-07-07 1991-01-09 Schering Corporation Pharmaceutically active compounds
HUT60458A (en) * 1991-02-01 1992-09-28 Sandoz Ag Process for producing benzyloxyphenyl derivatives and pharmaceutical compositions comprising same
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5409930A (en) * 1991-05-10 1995-04-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
GB9121943D0 (en) * 1991-10-16 1991-11-27 Sandoz Ltd Organic compounds,processes for their production and their use
US5656643A (en) * 1993-11-08 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Also Published As

Publication number Publication date
DE69616993T2 (de) 2002-07-04
HUP9801828A2 (hu) 1999-03-29
CA2214131C (en) 2009-06-23
DE69616993D1 (de) 2001-12-20
JP3194963B2 (ja) 2001-08-06
AU704544B2 (en) 1999-04-29
ATE208763T1 (de) 2001-11-15
MX9707022A (es) 1998-06-30
WO1996028430A1 (en) 1996-09-19
NO974118D0 (no) 1997-09-08
CZ289944B6 (cs) 2002-04-17
PT815087E (pt) 2002-04-29
KR100437580B1 (ko) 2004-07-16
FI973440A (fi) 1997-10-24
EP0815087B1 (en) 2001-11-14
DK0815087T3 (da) 2002-03-11
RU2164224C2 (ru) 2001-03-20
BR9607240A (pt) 1997-11-11
EP0815087A1 (en) 1998-01-07
SK282155B6 (sk) 2001-11-06
KR19980703049A (ko) 1998-09-05
ES2168463T3 (es) 2002-06-16
NZ304291A (en) 1999-01-28
AU5144396A (en) 1996-10-02
US5990116A (en) 1999-11-23
CN1183774A (zh) 1998-06-03
NO310356B1 (no) 2001-06-25
CN1101386C (zh) 2003-02-12
FI973440A0 (fi) 1997-08-21
NO974118L (no) 1997-09-08
FI120537B (fi) 2009-11-30
PL185875B1 (pl) 2003-08-29
PL322134A1 (en) 1998-01-05
SK124597A3 (en) 1998-01-14
CA2214131A1 (en) 1996-09-19
JPH11503412A (ja) 1999-03-26
HUP9801828A3 (en) 2001-02-28
CZ286997A3 (en) 1997-12-17

Similar Documents

Publication Publication Date Title
PL322134A1 (en) Trisubstituted phenyl derivatives
IL132608A0 (en) Fused dihydropyran compounds medicaments containing the same and the use thereof
BG105270A (en) Tetrahydropyridoethers
IL110031A0 (en) Phenyl heterocycles, their manufacture and pharmaceutical compositions containing them
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
NO307027B1 (no) Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
IL122782A0 (en) Pharmaceutical compositions for treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
CY2538B1 (en) Tetrahydropyrido compounds
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
MY135559A (en) Acylated aminoalkanimidazoles and - triazoles
ES2094545T3 (es) Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
MX9700624A (es) Azolidinonas de imidazopiridina.
AU1278600A (en) Novel therapeutic application of nicergoline
IL139144A0 (en) Mycobacterial inhibitors
NZ331165A (en) Verotoxin pharmaceutical compositions and medical treatments therewith
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
PL309339A1 (en) Novel triazoquinazolines, methods of obtaining them and their application
PT751774E (pt) Derivados de dissulfureto de mercaptoacetilamida hipocolesterolemicos
MY116727A (en) Tetrahydropyrido compounds
AU1278700A (en) Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline
MY133139A (en) N-substituted azabicycloheptane derivatives, their preparation and use

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110314